Overview

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

Status:
Recruiting
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Kochi University